SecSonar.com

Hyperfine, Inc. (HYPR)

Hyperfine, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Hyperfine, Inc. (HYPR) is a Medical - Devices company based in US with a market capitalization of $133.5M. Revenue grew 5.2% year-over-year and free cash flow was negative at -$29.1M. This page tracks HYPR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 111 employees · IPO Jan 28, 2021

Valuation

Valuation & price

$1.55 · as of May 17, 2026 · -29.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.26

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.09$1.43$0.77Jul 25Dec 25Jul 26Jul 7, 25$0.77Jul 9, 25$0.79Jul 11, 25$0.77Jul 15, 25$0.81Jul 17, 25$1.03Jul 21, 25$0.97Jul 23, 25$1.12Jul 25, 25$1.08Jul 29, 25$1.05Jul 31, 25$1.06Aug 4, 25$1.18Aug 6, 25$1.17Aug 11, 25$1.30Aug 13, 25$1.27Aug 15, 25$1.39Aug 19, 25$1.27Aug 21, 25$1.23Aug 25, 25$1.25Aug 27, 25$1.24Aug 29, 25$1.24Sep 3, 25$1.12Sep 5, 25$1.17Sep 9, 25$1.27Sep 11, 25$1.35Sep 16, 25$1.41Sep 18, 25$1.39Sep 22, 25$1.49Sep 24, 25$1.52Sep 26, 25$1.51Sep 30, 25$1.45Oct 2, 25$1.43Oct 6, 25$1.52Oct 8, 25$2.09Oct 10, 25$1.75Oct 14, 25$2.05Oct 16, 25$1.42Oct 21, 25$1.28Oct 23, 25$1.25Oct 27, 25$1.25Oct 29, 25$1.16Oct 31, 25$1.12Nov 4, 25$1.04Nov 6, 25$1.05Nov 10, 25$1.03Nov 12, 25$1.10Nov 14, 25$1.15Nov 18, 25$1.07Nov 20, 25$1.02Nov 25, 25$1.08Nov 28, 25$1.07Dec 2, 25$0.90Dec 4, 25$0.99Dec 8, 25$1.03Dec 10, 25$1.04Dec 12, 25$1.00Dec 16, 25$0.95Dec 18, 25$1.03Dec 22, 25$1.08Dec 24, 25$1.07Dec 29, 25$0.97Jan 2, 26$0.97Jan 6, 26$1.02Jan 8, 26$0.99Jan 12, 26$1.02Jan 14, 26$1.24Jan 16, 26$1.20Jan 21, 26$1.28Jan 23, 26$1.24Jan 27, 26$1.31Jan 29, 26$1.19Feb 2, 26$1.16Feb 4, 26$1.12Feb 9, 26$1.14Feb 11, 26$1.10Feb 13, 26$1.11Feb 18, 26$1.14Feb 20, 26$1.15Feb 24, 26$1.10Feb 26, 26$1.13Mar 2, 26$1.06Mar 4, 26$1.10Mar 6, 26$1.07Mar 10, 26$1.16Mar 12, 26$1.17Mar 17, 26$1.30Mar 19, 26$1.21Mar 23, 26$1.21Mar 25, 26$1.17Mar 27, 26$1.11Mar 31, 26$1.08Apr 2, 26$1.13Apr 7, 26$1.11Apr 9, 26$1.21Apr 13, 26$1.24Apr 15, 26$1.29Apr 17, 26$1.31Apr 22, 26$1.30Apr 24, 26$1.29Apr 28, 26$1.30Apr 30, 26$1.66May 4, 26$1.81May 6, 26$1.73May 8, 26$1.69May 12, 26$1.73May 14, 26$1.60May 18, 26$1.45May 20, 26$1.48May 22, 26$1.49May 28, 26$1.60Jun 1, 26$1.52Jun 3, 26$1.49Jun 5, 26$1.38Jun 9, 26$1.42Jun 11, 26$1.42Jun 15, 26$1.38Jun 17, 26$1.39Jun 22, 26$1.49Jun 24, 26$1.46Jun 26, 26$1.47Jul 2, 26$1.30
$0.7752-week range$2.20
Loading valuation history…

Fundamentals

Key fundamentals

$133.5M

Market cap

5.2%

Revenue growth (YoY)

49.8%

Gross margin

-$29.1M

Free cash flow (USD)

-$34.8M

Net debt

Net cash position

30.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$294.0KFY 2021$1.5MFY 2022$6.8MFY 2023$11.0MFY 2024$12.9MFY 2025$13.6M
$0$13.6M

Free cash flow by year

2019 → 2025

FY 2019$-18.6MFY 2020$-23.1MFY 2021$-49.9MFY 2022$-72.9MFY 2023$-42.6MFY 2024$-39.1MFY 2025$-29.1M
-$18.6M-$29.1M

Gross margin by year

2021 → 2025

FY 2021-78.0%FY 202213.3%FY 202343.1%FY 202445.7%FY 202549.8%
-78.0%49.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $10KTEISSEYRE THOMAS · Chief Operating Officer · $10KMay 27, 2026Filing
  • Insider sellInsider Sell $10KHALE BRETT · CFO and CAO · $10KMay 27, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 21, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • FinancingSecurities RegistrationMay 12, 2026Filing

Questions

Frequently asked questions

What is Hyperfine, Inc.'s market cap?

Hyperfine, Inc. (HYPR) has a market capitalization of $133.5M.

What is HYPR's P/E ratio?

A meaningful P/E ratio is not available for HYPR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is HYPR's price-to-book (P/B) ratio?

HYPR trades at 3.26 times book value per share.

Are insiders buying HYPR stock?

SEC Form 4 filings show no open-market insider buys at Hyperfine, Inc. in the last 90 days (2 sells).

Same arena

Related companies in Medical - Devices

NNOX

Nano-X Imaging Ltd.

$134.7M

MXCT

MaxCyte, Inc.

$135.5M

QTI

QT Imaging Holdings, Inc.

$136.9M

TLSI

TriSalus Life Sciences, Inc.

$128.5M

SNWV

SANUWAVE Health, Inc.

$143.2M

QTRX

Quanterix Corporation

$146.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.